Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Join Channel
Consolidated Standalone

Alembic

₹88.4 2.3 | 2.7%

Market Cap ₹2269 Cr.

Stock P/E 9.3

P/B 1.1

Current Price ₹88.4

Book Value ₹ 82.9

Face Value 2

52W High ₹107.5

Dividend Yield 2.49%

52W Low ₹ 63.5

Edit Ratio

Alembic Research see more...

Overview Inc. Year: 1907Industry: Pharmaceuticals & Drugs

Alembic Ltd is engaged in the business of pharma, real estate and power assets. It's segments are Real Estate and API. The Company's pharma enterprise is engaged in manufacturing and advertising of fermentation and chemistry-based API. It is also engaged in R&D at Vadodara. The Company's Real Estate business is engaged in the construction of residential and industrial real estate projects and project management and advertising consultancy. The Company is also involved in industrial houses on hire basis to various tenants. The Company is engaged in power generation via co-generation, which includes co-generation plants of approximately 10 megawatts, and Wind Power, which incorporates Windmills of about five megawatts. Its plant places cosists of Alembic Road, Vadodara; Wind Mills at village Ukharla/Trambak, Bhavnagar, Gujarat, and Construction tasks at Chhani, Vadodara.

Read More..

Alembic Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Alembic Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 20 19 18 22 37 31 37 37 32 39
Other Income 81 2 4 1 59 2 2 3 48 2
Total Income 101 21 23 23 97 33 39 39 80 42
Total Expenditure 17 16 15 17 26 20 24 26 22 28
Operating Profit 84 6 7 6 70 13 15 14 58 14
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 1 1 1 2 2 2 2 2 2 3
Exceptional Income / Expenses 0 0 0 0 0 0 -11 0 0 0
Profit Before Tax 83 4 6 4 68 11 3 12 56 11
Provision for Tax 9 0 1 0 7 0 -2 2 4 1
Profit After Tax 74 4 5 4 61 11 5 10 52 10
Adjustments 47 48 -4 -22 54 35 44 34 39 52
Profit After Adjustments 120 52 1 -19 115 46 48 44 91 61
Adjusted Earnings Per Share 4.7 2 0 -0.7 4.5 1.8 1.9 1.7 3.5 2.4

Alembic Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 144 128 147 125 124 74 74 78 127 145
Other Income 22 29 31 37 30 94 11 89 64 55
Total Income 166 156 178 162 154 167 84 167 192 200
Total Expenditure 135 122 140 114 106 71 63 64 87 100
Operating Profit 30 35 38 48 48 97 21 103 105 101
Interest 1 0 0 0 0 0 0 0 0 0
Depreciation 6 6 5 4 3 3 4 5 7 9
Exceptional Income / Expenses 0 -3 -6 0 0 0 0 0 -11 -11
Profit Before Tax 23 25 27 44 45 93 17 98 87 82
Provision for Tax -1 1 -1 2 4 0 3 12 6 5
Profit After Tax 24 25 27 42 41 93 14 86 81 77
Adjustments 82 210 118 121 172 236 329 136 110 169
Profit After Adjustments 107 235 145 163 213 329 343 222 191 244
Adjusted Earnings Per Share 4 8.8 5.4 6.1 8.3 12.8 13.4 8.6 7.4 9.5

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 63% 20% 0% 0%
Operating Profit CAGR 2% 3% 17% 0%
PAT CAGR -6% -5% 14% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 37% -13% 16% 18%
ROE Average 4% 3% 4% 4%
ROCE Average 4% 3% 4% 4%

Alembic Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 528 803 911 1086 1209 1418 2297 2497 2078
Minority's Interest 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 38 15 13 14 9 7 53 68 43
Total Current Liabilities 82 58 68 59 49 46 59 68 84
Total Liabilities 648 875 992 1159 1266 1471 2409 2632 2205
Fixed Assets 169 146 148 132 131 131 134 134 132
Other Non-Current Assets 289 560 654 840 1036 1177 2173 2355 1901
Total Current Assets 189 169 191 185 99 163 102 143 172
Total Assets 648 875 992 1159 1266 1471 2409 2632 2205

Alembic Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 1 3 2 2 1 2 58 6 1
Cash Flow from Operating Activities 22 10 52 24 22 7 -2 -18 39
Cash Flow from Investing Activities 5 -5 -47 -22 72 57 -35 19 7
Cash Flow from Financing Activities -25 -5 -5 -3 -92 -6 -15 -6 -46
Net Cash Inflow / Outflow 2 -0 -0 -1 1 57 -52 -5 -0
Closing Cash & Cash Equivalent 3 2 2 1 2 59 6 1 1

Alembic Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 3.99 8.78 5.44 6.1 8.3 12.82 13.35 8.65 7.42
CEPS(Rs) 1.13 1.16 1.22 1.71 1.7 3.75 0.69 3.55 3.4
DPS(Rs) 0.15 0.15 0.2 0.2 0.2 0.6 0.2 1.8 2.2
Book NAV/Share(Rs) 19.77 30.08 34.13 40.66 47.06 55.22 89.45 97.23 80.93
Core EBITDA Margin(%) 5.75 4.47 4.39 8.72 14.01 4.25 14.18 17.81 31.7
EBIT Margin(%) 16.24 18.98 17.51 34.9 36.26 126.41 23.67 125.61 68.58
Pre Tax Margin(%) 15.69 18.89 17.4 34.76 36.08 126.02 23.18 125.11 68.21
PAT Margin (%) 16.15 18.44 17.97 32.88 33.18 125.85 18.83 110.2 63.36
Cash Profit Margin (%) 20.18 23.02 21.29 35.85 35.3 130.21 24.19 116.42 68.64
ROA(%) 2.88 3.25 2.94 3.88 3.39 6.8 0.71 3.42 3.33
ROE(%) 5.58 3.71 3.21 4.18 3.58 7.08 0.75 3.6 3.52
ROCE(%) 3.82 3.82 3.12 4.44 3.91 7.12 0.94 4.1 3.82
Receivable days 293.96 103.47 59.14 67.34 57.19 55.52 56.58 67.74 55.47
Inventory Days 401.78 216.71 149.7 119.22 99.84 174.64 222.67 329.34 251.69
Payable days 534.49 93.12 58.96 72.48 112.21 565.67 252.73 299.17 162.67
PER(x) 8.68 4.02 6.73 8.73 5.09 2.79 7.7 8.37 7.99
Price/Book(x) 1.75 1.17 1.07 1.31 0.9 0.65 1.15 0.74 0.73
Dividend Yield(%) 0.43 0.42 0.55 0.38 0.47 1.68 0.19 2.49 3.71
EV/Net Sales(x) 6.41 7.37 6.63 11.35 8.75 11.6 35.84 23.73 11.95
EV/Core EBITDA(x) 30.42 27.02 25.91 29.56 22.79 8.87 123.44 18 14.54
Net Sales Growth(%) -87.35 -11.41 15.4 -14.86 -1.19 -40.29 -0.55 6.39 62.68
EBIT Growth(%) -70.3 4.74 5.28 65.54 1.23 108.18 -81.38 464.53 -11.18
PAT Growth(%) -38.92 2.37 11.2 51.99 -1.67 126.45 -85.12 522.73 -6.47
EPS Growth(%) 169.6 119.99 -38 12.1 35.97 54.44 4.17 -35.23 -14.15
Debt/Equity(x) 0 0 0 0 0 0 0 0 0
Current Ratio(x) 2.32 2.93 2.8 3.14 2.02 3.56 1.72 2.12 2.05
Quick Ratio(x) 1.28 1.64 2.06 2.69 1.3 2.78 0.8 0.83 1
Interest Cover(x) 29.3 221.26 169.23 261.78 207.64 324.49 48.08 252.5 187.54
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0

Alembic Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 70.88 70.88 70.88 70.88 70.88 70.88 70.88 70.88 70.88 70.88
FII 1.19 1.12 1.08 0.83 0.82 0.7 0.72 0.85 0.89 1.07
DII 5.17 4.68 4.29 4.12 3.95 3.95 3.93 3.4 0.04 0.04
Public 22.76 23.31 23.75 24.16 24.35 24.48 24.46 24.87 28.18 28.01
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Debtor days have improved from 299.17 to 162.67days.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 3% over the last 3 years.
  • Earnings include an other income of Rs. 64 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Alembic News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!